{
  "report_rows": [
    {
      "kpi": "Q2 2026 net sales",
      "prediction": "BEAT",
      "answer": "pred ~$1.380B vs. cons $1.356B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted operating EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$418M vs. cons $413.1M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.08 vs. cons $1.06",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Full-year net sales guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$5.375B vs. cons $5.373B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year adjusted operating EBITDA guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$1.625B vs. cons $1.617B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year adjusted EPS guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$4.15 vs. cons $4.16 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year adjusted free-cash-flow guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$550M vs. cons $431.5M (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 4.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.6,
  "day5_path": "FADE",
  "day5_rationale": "The predicted Q2 revenue beat is ~$24M versus consensus, but FY2026 sales guidance of ~$5.375B versus consensus of $5.373B implies H2 sales of only ~$2.680B versus the pre-report consensus math of ~$2.702B. Likewise, EPS guidance of ~$4.15 versus $4.16 leaves implied H2 EPS near ~$1.99 versus ~$2.02. Those implicit out-period cuts should partially offset the EBITDA raise and fade the initial beat-driven reaction.",
  "day5_confidence": "MEDIUM"
}